Stockscreener 앱 받기
11.32
8.74%
0.91
전일 마감가:
$10.41
열려 있는:
$10.73
하루 거래량:
2.52M
Relative Volume:
2.99
시가총액:
$1.05B
수익:
$79.76M
순이익/손실:
$-120.53M
주가수익비율:
-7.6024
EPS:
-1.489
순현금흐름:
$3.75M
1주 성능:
+17.92%
1개월 성능:
+20.43%
6개월 성능:
+42.21%
1년 성능:
+74.69%
1일 변동 폭
$10.61
$11.74
1주일 범위
$9.51
$11.74
52주 변동 폭
$6.07
$11.85
Meiragtx Holdings Plc Stock (MGTX) Company Profile
명칭
Meiragtx Holdings Plc
전화
646-860-7985
주소
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
11.32 | 1.05B | 79.76M | -120.53M | 3.75M | -1.489 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | H.C. Wainwright | Buy |
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-07-31 | 재개 | Chardan Capital Markets | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-09-15 | 재개 | BofA Securities | Buy |
| 2019-09-03 | 개시 | Piper Jaffray | Overweight |
| 2019-02-27 | 재확인 | Chardan Capital Markets | Buy |
| 2018-07-03 | 개시 | Barclays | Overweight |
| 2018-07-03 | 개시 | BofA/Merrill | Buy |
모두보기
Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스
MGTX | MeiraGTx Holdings plc Ordinary FinancialsIncome Statement - Quiver Quantitative
MeiraGTx Holdings StockThursday technicals after recent rally - AD HOC NEWS
MeiraGTx Holdings PLC (MGTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MeiraGTx Holdings PLC (MGTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MeiraGTx Holdings PLC (MGTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MeiraGTx Holdings PLC (MGTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
MeiraGTx Holdings PLC (MGTX) Institutional Confidence - TradingKey
MeiraGTx Holdings PLC (MGTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MeiraGTx Holdings PLC (MGTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MeiraGTx Holdings PLC (MGTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MeiraGTx Holdings PLC (MGTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
What Could MeiraGTx’s Latest Equity Award Reveal About Long-Term Alignment? - Kalkine Media
MeiraGTx Holdings plc Announces 2026 Annual Meeting Results and Auditor Appointment - Minichart
MeiraGTx (MGTX) director Harris Keith R. granted 106,441 restricted share units - Stock Titan
Director at MeiraGTx (NASDAQ: MGTX) receives 60,000 RSUs grant - Stock Titan
MeiraGTx shareholders elect directors and approve auditor at annual meeting - Investing.com
MeiraGTx Shareholders Back Board Slate and Auditor Renewal - TipRanks
MeiraGTx (MGTX) investors back board slate and Ernst & Young - Stock Titan
MeiraGTx (MGTX) awards 60,000 RSUs tied to Perceptive Advisors board service - Stock Titan
MeiraGTx Holdings PLC (MGTX) reports Q1 loss, lags revenue estimates - MSN
MeiraGTx (MGTX) director converts 75,000 RSUs, boosting holdings to 200,000 shares - Stock Titan
Liquidity Mapping Around (MGTX) Price Events - Stock Traders Daily
MeiraGTx Holdings stock (US58550P1012): FDA breakthrough designation lifts focus on radiation dry mo - AD HOC NEWS
Transcript : MeiraGTx Holdings plc Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 03 - marketscreener.com
MeiraGTx Holdings plc (MGTX) Presents at Jefferies Global Healthcare Conference 2026Slideshow - Seeking Alpha
MeiraGTx Q1 2026 Earnings: Wider‑than‑expected loss highlights ongoing R&D investmentEstimate Revision Count - newsline.com
MGTX: Pivotal gene therapy programs advance toward approval, with strong data and market readiness - TradingView
MeiraGTx Holdings Hits Day Low of $9.78 Amid Price Pressure - MarketsMojo
MeiraGTx Holdings plc Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Clinical-Stage R&D CostsProfit Cycle Analysis - newsline.com
MeiraGTx Holdings Plc Announces Amendment To $100,000,000 Fluctuating Rate Senior Secured Loan Notes Maturity Date - marketscreener.com
Certain Stock Options of MeiraGTx Holdings plc are subject to a Lock-Up Agreement Ending on 1-JUN-2026. - marketscreener.com
Certain Restricted Stock Units of MeiraGTx Holdings plc are subject to a Lock-Up Agreement Ending on 1-JUN-2026. - marketscreener.com
Certain Ordinary Shares of MeiraGTx Holdings plc are subject to a Lock-Up Agreement Ending on 1-JUN-2026. - marketscreener.com
Why (MGTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
MeiraGTx Holdings (MGTX) Surges 6.5% as Biotech Sector Momentum BuildsStock Analysis - thelegaladvocate.com
MeiraGTx Q1 2026 Earnings: Wider-than-Expected Loss but Stock Gains on Pipeline ProgressQuarterly Financial Update - The Legal Advocate
MeiraGTx (MGTX) CFO & COO Giroux reports bona fide gift of 7,000 shares - Stock Titan
MeiraGTx Holdings (MGTX) Edges Higher, Hovers Above Key SupportSafe Entry Stocks - The Legal Advocate
H.C. Wainwright Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
MeiraGTx Holdings (MGTX) Pulls Back Nearly 3% as Stock Tests Near Key Support LevelRisk Reversal - newsline.com
MeiraGTx Holdings | 4: Statement of changes in beneficial ownership of securities-Officer Wollin Robert J - Moomoo
MeiraGTx Holdings plc (MGTX) Q1 2026 Earnings: Wider-than-Expected Loss Stings InvestorsEarnings Call Highlights - The Legal Advocate
MeiraGTx Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineDividend Increase Stocks - newsline.com
MGTX Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances PipelinePost-Earnings Reaction - The Legal Advocate
MeiraGTx Holdings plc (MGTX) Q1 2026 Earnings: Wider-than-Expected Loss Amid Clinical ProgressEarnings Forecast Report - The Legal Advocate
MeiraGTx Q1 2026 Earnings: Wider-than-Expected Loss Highlights Cash Burn Amid Clinical ProgressEarnings Per Share - The Legal Advocate
Chardan Capital Maintains MeiraGTx Holdings (MGTX) Buy Recommendation - MSN
MeiraGTx Holdings stock (US58550P1012): Insider selling draws attention as gene therapy story evolve - AD HOC NEWS
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint - Insider Monkey
Meiragtx president & CEO Forbes Alexandria sells $568,540 in shares By Investing.com - Investing.com India
Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei - GuruFocus
Meiragtx Holdings Plc (MGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.44%
자본화:
|
볼륨(24시간):